Lactose (India) Limited (BSE: 524202)
Health Care · Pharmaceuticals · IN
Rs100.00
-6.93% today · -9.2% 1Y
Lactose (India) Limited (BSE: 524202) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $13.16M.
Over the last twelve months the share price has lost 9.2%, trading between 76.01 and 136.70.
Tweenvest scores Lactose (India) Limited across four factors: quality 55/100, value 77/100, growth 93/100. Its strongest factor is growth.
524202 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $13.16M
- Revenue (TTM)
- $18.05M
- P/E
- 18.57
- EPS
- 5.38
- Dividend yield
- —
- Beta (5Y)
- 0.74
- 52-week high
- Rs136.70
- 52-week low
- Rs76.01
- Avg volume (3M)
- —
- Shares outstanding
- 12.59M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,233.50 | -0.01% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $273.20 | +0.02% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $155.85 | -0.38% |
| Roche Holding AGSWX: ROP | $371.62B | CHF369.70 | -1.10% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £122.92 | -1.47% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.52 | -0.18% |
Figures last refreshed Aug 18, 2026.